with the final flexible solar cell peeling off the glass. This process differs from more traditional methods that tend to be built directly onto plastic. “Unlike conventional methods that use ...

Access includes Asimov’s CHO Edge cell line development platform and Cytiva’s HyClone™ media and feed solutions, along with Cytiva’s Fast Trak™ process development services.

The new offering will provide seamless access to Asimov’s CHO Edge cell line development platform, Cytiva's HyClone media and feed solutions, and Cytiva’s Fast Trak process development services.

The risk of developing blood cancer increases with age. The finding that a molecule from gut bacteria plays a part points to ...

that serves as valuable guidance for product-by-process claims, particularly in the context of inherency in claim construction. In Restem, LLC v. Jadi Cell, LLC, the Court affirmed the Patent Tria ...

The Company has been selected to deliver an oral presentation on the translational data from its Phase 1 clinical trial of FT522, an off-the-shelf, CD19-targeted CAR NK cell product candidate, in ...

In the most recent round of cuts, various senior negotiators at the FDA who talk with pharmaceutical companies to renew user fee programs that fund the drug review system were laid off ...

The study reports that patients receiving multiple intravenous infusions of this "off-the-shelf" Treg therapy ... standardized fixed dose of 100 million cells. The regimen included weekly ...

Nearly half of the Centers for Disease Control and Prevention's staff working on developmental disabilities and birth defects was laid off this month, multiple officials tell CBS News, wiping out ...

The Company has been selected to deliver an oral presentation on the translational data from its Phase 1 clinical trial of FT522, an off-the-shelf, CD19-targeted CAR NK cell product candidate ...